Moreover, TLR2 and TLR4 activity was markedly increased in association with elevated TNF-α, IL-6, and IFN-γ expressions, increased insulin resistance in response to inflammation; the changes were more prominent in diabetic patients with end-stage renal disease and renal failure. Here, TLR2 is linked to stage 5 chronic kidney disease.